Aurobindo Accesses Russian OTC Market Through Deal With Diod
This article was originally published in The Tan Sheet
Executive Summary
Indian company Aurobindo Pharma stakes a claim in Russia’s surging consumer health product market with a joint venture to market OTC and generic drugs.
You may also be interested in...
Central, Eastern Europe Lead OTC Growth On Sector’s Top Continent
Central and Eastern Europe continue to drive OTC sales growth on the continent, with even low-growth countries matching the best levels in Western Europe.
J&J Expands Russian OTC Foothold Via J.B. Chemicals Portfolio Acquisition
Johnson & Johnson expands its consumer health presence in Russia and other Eastern European markets with the acquisition of several OTC brands from J.B. Chemicals & Pharmaceuticals.
Russia Pledges $3.9 Billion For Local Pharma Growth, As Big Pharma Scrambles To Set Up Shop
Russia has called for half of all pharmaceuticals in the country to be produced domestically in the next decade, pledging to spend 122.9 billion rubles ($3.97 billion) to get international drug makers to shift drug production to the country and strengthen R&D collaboration